LG Chem growth hormone mobile app. EuDi
LG Chem growth hormone mobile app. EuDi
LG Chem growth hormone mobile app. EuDi
LG Chem growth hormone mobile app. EuDi
LG Chem growth hormone mobile app. EuDi
LG Chem growth hormone mobile app. EuDi
LG Chem growth hormone mobile app. EuDi
LG Chem growth hormone mobile app. EuDi
LG Chem growth hormone mobile app. EuDi
LG Chem growth hormone mobile app. EuDi
2024

Share:

LG Chem growth hormone mobile app. EuDi

Mobile app.

EuDi is the first growth hormone-dedicated application developed in Korea for infants and their caregivers using LG Chem's growth hormone 'Eutropin'. Given growth hormone administration usually involves a daily subcutaneous injection by the caregiver to the child at a specific time for about 6 months to a year, many children often have an aversion to injections. EuDi is designed to transform this long-term injection experience into a delightful and enjoyable one, with the help of the EuDi character.

Client / Manufacturer

LG Chem

Hwa-Gok Dong, Gang-Seo Gu, Seoul, KR
Design

LG Chem

Hwa-Gok Dong, Gang-Seo Gu, Seoul, KRHyewon Lee

4M CREATIVE INC.

Seoul, KROuk Kim

DESIGN AILE

Seoul, KRKiyoon Jeong
Date of Launch
2021
Development Time
up to 6 Month
Target Regions
Asia
Target Groups
Consumers / Users, Trade / Industry

RELATED PROJECTS